Key result
Salmonella enterica and its specific lipopolysaccharide O-antigen or core components enhance the infectivity and stability of Coxsackievirus B3 in vitro.
Why the study?
Enteric viruses can utilize intestinal bacteria to promote viral replication and pathogenesis, but the precise interactions between enteric viruses and bacteria are unknown.
Specific bacterial cell wall components, such as the O-antigen or core of lipopolysaccharide in S. enterica, dictate the enhancement of Coxsackievirus B3 infectivity and stability in vitro, highlighting virus-specific interactions with intestinal bacteria.
Suggests intestinal bacteria may modulate coxsackievirus pathogenesis; leaves open clinical implications pending in vivo validation.
Enteric viruses infect the mammalian gastrointestinal tract and lead to significant morbidity and mortality worldwide. Data indicate that enteric viruses can utilize intestinal bacteria to promote viral replication and pathogenesis. However, the precise interactions between enteric viruses and bacteria are unknown. Here we examined the interaction between bacteria and Coxsackievirus B3, an enteric virus from the picornavirus family. We found that bacteria enhance the infectivity of Coxsackievirus B3 (CVB3) in vitro. Notably, specific bacteria are required as gram-negative Salmonella enterica , but not Escherichia coli , enhanced CVB3 infectivity and stability. Investigating the cell wall components of both S. enterica and E. coli revealed that structures in the O-antigen or core of lipopolysaccharide, a major component of the gram-negative bacterial cell wall, were required for S. enterica to enhance CVB3. To determine if these requirements were necessary for similar enteric viruses, we investigated if S. enterica and E. coli enhanced infectivity of poliovirus, another enteric virus in the picornavirus family. We found that, in contrast to CVB3, these bacteria enhanced the infectivity of poliovirus in vitro. Overall, these data indicate that distinct bacteria enhance CVB3 infectivity and stability, and specific enteric viruses may have differing requirements for their interactions with specific bacterial species. Importance Previous data indicate that several enteric viruses utilize bacteria to promote intestinal infection and viral stability. Here we show that specific bacteria and bacterial cell wall components are required to enhance infectivity and stability of Coxsackievirus B3 in vitro. These requirements are likely enteric virus-specific as the bacteria for CVB3 differs from poliovirus, a closely related virus. Therefore, these data indicate that specific bacteria and their cell wall components dictate the interaction with various enteric viruses in distinct mechanisms.
No takes yet. Share an insight, caveat, or question.
Dhalech et al. (2021) studied Coxsackievirus B3 infection. Salmonella enterica and its lipopolysaccharide (LPS) vs. PBS or E. coli was evaluated on Viral infectivity and stability (decay rate). Salmonella enterica and its specific lipopolysaccharide O-antigen or core components enhance the infectivity and stability of Coxsackievirus B3 in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: